Drug Profile
IDH1 and IDH2 companion diagnostic - Abbott Laboratories
Alternative Names: Abbott RealTime IDH1 Assay; Abbott RealTime IDH2; Enasidenib companion diagnostic; Olutasidenib companion diagnosticLatest Information Update: 08 Dec 2022
Price :
$50
*
At a glance
- Originator Abbott Laboratories; Celgene Corporation
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute myeloid leukaemia